Bio-Novum sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-11-09
Share capital
160,000.00 PLN
Activity description

Bio-Novum is a company specializing in medical laboratory diagnostics and biotechnology, providing high-specialty diagnostic tests for healthcare facilities and research institutions. Their product offerings include rapid diagnostic tests, immunochemical tests, and solutions for automating the erythrocyte sedimentation rate (ESR) test, as well as tests for detecting SARS-CoV-2 infections. Additionally, Bio-Novum represents companies from South Korea, the United States, and China in Poland.

Registered address
ul. Nowy Świat 23A/3u, 20-418 Lublin, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-47211-22183-JBEWR-22

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 68 days late).

  • 202525/06/2026
  • 202412/06/2025
  • 202313/06/2024
  • 202228/06/2023
  • 202121/09/2022
  • 202004/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods424 / 1,136
Top 37%
Division · Wholesale trade5,471 / 20,037
Top 27%
City · Lublin513 / 4,827
Top 11%
Voivodeship · Lubelskie1,392 / 10,168
Top 14%
Country · Poland43,215 / 297,069
Top 15%

Results vs industry

Revenue
This companyUSD 3.46mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 649.39kMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 2.71mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 2.25mMedianUSD 610.11kAverageUSD 11.92m

Offer

  • Immunochemistry analysers
  • Diagnostic tests
  • Immunochromatographic tests
  • ESR analysers
  • Psychoactive substance detection tests

Websites

  • bio-novum.comBio-Novum
    WordPress 3.7Apache
  • e-bio-novum.comTesty diagnostyczne, POCT i aparatura medyczna | Bio-Novum
    Google AnalyticsGoogle Tag ManagerApache

Public procurement

182 tenders recorded as contractor: 122 national ($2,548,361) and 60 EU ($1,041,530).

SubjectAmount
Supply of chemical reagents and reagent kits together with consumables and lease of an analyser for measuring infliximab concentration for a period of 24 months.
$36,434
Purchase of rapid cassette tests and reagents.
–
Purchase and supply of chemical reagents with accessories and rental of analyzers
–

Authorized Representatives

Piotr Adam Rubaj age 58 – Management Board Member
Artur Marcin Golus age 42 – Management Board Member

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
79$21,339.8249.375%
80$21,609.9450%
Others
1$270.120.625%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-11-16.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

13 public aid cases recorded, with a total value of $220,190.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,960
Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies
$63
De minimis aid (in accordance with Commission Regulation 2023/2831)
$4,241

European Funds

ProjectEU co-financing
Development of operations and internationalisation of Bio-Novum Sp. z o. o.
$34,267
Bio-Novum Sp. z o. o. in foreign markets.
$32,707
Internationalisation of the offer of Bio-Novum Sp. z o.o.
$131.6K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
EMMA Mdt sp. z o.o.
Bionesis sp. z o.o.
Diather Petrusewicz sp. k.
Integra Diagnostic sp. z o.o.
HVD Holding Ag sp. z o.o.
Medlab-Products sp. z o.o.
Fabimex Więcek sp. j.
Asamed sp. z o.o.
Horien Medical sp. z o.o.
Cybimed sp. z o.o.

Change history

DateEvent
2021-05-06Address change
2021-02-15Share capital increase
2018-11-09Entered in the register

FAQ

Last updated: 2026-06-25